Skip to main content

Advertisement

Log in

Perception of risk regarding the use of medications and other exposures during pregnancy

  • Pharmacoepidemiology and Prescription
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

Background

Perception of risk may impact a woman’s decision to take a needed drug during pregnancy. There is a paucity of research on this topic in the literature.

Objectives

(1) To evaluate the perception of risk of 17 commonly used drugs and other substances by pregnant women. (2) To investigate which sources of information regarding exposures during pregnancy were most commonly used by women.

Methods

A questionnaire was developed through the University of Oslo’s website for Internet surveys and posted on four Web pages used by pregnant women and mothers, from mid-September 2008 through October 2008. The inclusion criteria included women who were (1) pregnant or 2) a mother of a child less than 5 years old.

Results

A total of 1,793 eligible women completed the questionnaire. Most women overestimated the teratogenic risk associated with all the drugs during pregnancy. Characteristics of the women that were associated with a high perception of risk were primiparity, higher age, higher education, and choosing not to use a drug during pregnancy. More than 80% of the women had used drugs during pregnancy, mostly paracetamol, penicillins and reflux medications. The physician, the product information leaflet and the pharmacist were the three most frequently used sources of information.

Conclusion

Women overestimate the risk of drug use and other exposures during pregnancy. Therefore, it is important for health care providers to use evidence-based information, to reduce unnecessary anxiety, and to ensure safe and appropriate treatment during pregnancy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Finer LB, Henshaw SK (2006) Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspect Sex Reprod Health 38(2):90–96

    Article  PubMed  Google Scholar 

  2. Sanz E, Gomez-Lopez T, Martinez-Quintas MJ (2001) Perception of teratogenic risk of common medicines. Eur J Obstet Gynecol Reprod Biol 95(1):127–131

    Article  CAS  PubMed  Google Scholar 

  3. Einarson A (2007) The way women perceive teratogenic risk: how it can influence decision making during pregnancy regarding drug use or abortion of a wanted pregnancy. In: Koren G (ed) Medication safety in pregnancy and breastfeeding. McGraw-Hill, New York, pp 309–312

  4. Hancock RL, Koren G, Einarson A, Ungar WJ (2007) The effectiveness of Teratology Information Services (TIS). Reprod Toxicol 23(2):125–132

    Article  CAS  PubMed  Google Scholar 

  5. Koren G, Bologa M, Long D, Feldman Y, Shear NH (1989) Perception of teratogenic risk by pregnant women exposed to drugs and chemicals during the first trimester. Am J Obstet Gynecol 160(5.1):1190–1194

    CAS  PubMed  Google Scholar 

  6. Bonari L, Koren G, Einarson TR, Jasper JD, Taddio A, Einarson A (2005) Use of antidepressants by pregnant women: evaluation of perception of risk, efficacy of evidence based counseling and determinants of decision making. Arch Womens Ment Health 8(4):214–220

    Article  CAS  PubMed  Google Scholar 

  7. Organization of Teratology Information Specialists (OTIS) (2009) Home page. http://www.otispregnancy.org/hm/. Accessed 27 February 2009

  8. European Network of Teratology Information Services (ENTIS) (2009) Home page. http://www.entis-org.com/. Accessed 27 February 2009

  9. Sinikovic DS, Yeatman HR, Cameron D, Meyer BJ (2009) Women’s awareness of the importance of long-chain omega-3 polyunsaturated fatty acid consumption during pregnancy: knowledge of risks, benefits and information accessibility. Public Health Nutr 12(4):562–569

    Article  PubMed  Google Scholar 

  10. Bondarianzadeh D, Yeatman H, Condon-Paoloni D (2007) Listeria education in pregnancy: lost opportunity for health professionals. Aust N Z J Public Health 31(5):468–474

    Article  PubMed  Google Scholar 

  11. van Trigt AM, Waardenburg CM, Haaijer-Ruskamp FM, de Jong-van den Berg LT (1994) Questions about drugs: how do pregnant women solve them? Pharm World Sci 16(6):254–259

    Article  PubMed  Google Scholar 

  12. Larsson M (2009) A descriptive study of the use of the Internet by women seeking pregnancy-related information. Midwifery 25(1):14–20

    Article  PubMed  Google Scholar 

  13. Koren G, Gladstone D, Robeson C, Robieux I (1992) The perception of teratogenic risk of cocaine. Teratology 46(6):567–571

    Article  CAS  PubMed  Google Scholar 

  14. Schaefer C, Peters PWJ, Miller RK (eds) (2007) Drugs during pregnancy and lactation. Treatment options and risk assessment, 2nd ed. Academic Press, New York

  15. Bentur Y, Horlatsch N, Koren G (1991) Exposure to ionizing radiation during pregnancy: perception of teratogenic risk and outcome. Teratology 43(2):109–112

    Article  CAS  PubMed  Google Scholar 

  16. University of Oslo, Norway (2009) Nettskjema. nettskjema.uio.no/index.html?lang=en. Accessed March 2009

  17. John OP, Benet-Martinez V (2000) Measurement: reliability, construct validation, and scale construction. In: Reis HT, Judd CM (eds) Handbook of research methods in social and personality psychology. Cambridge University Press, New York, pp 339–369

    Google Scholar 

  18. Norwegian Institute of Public Health (2006) Medical birth registry of Norway annual report 2003–2004. NIPS, Oslo

  19. Statistics Norway (2008) Population. Table 03031: population by sex, age and marital status 2008. http://www.ssb.no/english/. Accessed 1 December 2009

  20. Statistics Norway (2007) Education level in the population. Table 3: population 16 years and over by, by level of education, gender and age 2007. http://www.ssb.no/english/. Accessed 1 December 2009

  21. Gendron MP, Martin B, Oraichi D, Bérard A (2009) Health care providers’ requests to Teratogen Information Services on medication use during pregnancy and lactation. Eur J Clin Pharmacol 65(5):523–531

    Article  PubMed  Google Scholar 

  22. Frost Widnes SK, Schjøtt J (2008) Advice on drug safety in pregnancy: are there differences between commonly used sources of information? Drug Saf 31(9):799–806

    Article  PubMed  Google Scholar 

  23. Holst L, Wright D, Nordeng H, Haavik S (2009) Use of herbal preparations during pregnancy. focus group discussion among expectant mothers attending a hospital antenatal clinic in Norwich UK. Complement Ther Clin Pract (in press)

  24. Zaffani S, Cuzzolin L, Benoni G (2006) Herbal products: behaviors and beliefs among Italian women. Pharmacoepidemiol Drug Saf 15(5):354–335

    Article  PubMed  Google Scholar 

  25. Cohen-Kerem R, Nulman I, Abramow-Newerly M, Medina D, Maze R, Brent RL, Koren G (2006) Diagnostic radiation in pregnancy: perception versus true risks. J Obstet Gynaecol Can 28(1):43–48

    PubMed  Google Scholar 

  26. Ratnapalan S, Bona N, Chandra K, Koren G (2004) Physicians’ perceptions of teratogenic risk associated with radiography and CT during early pregnancy. AJR Am J Roentgenol 182(5):1107–1109

    PubMed  Google Scholar 

  27. Statistics Norway (2008) Use of ICT in households, 2nd quarter 2008. http://www.ssb.no/english/subjects/10/03/ikthus_en/. Accessed 1 December 2008

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hedvig Nordeng.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nordeng, H., Ystrøm, E. & Einarson, A. Perception of risk regarding the use of medications and other exposures during pregnancy. Eur J Clin Pharmacol 66, 207–214 (2010). https://doi.org/10.1007/s00228-009-0744-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-009-0744-2

Keywords

Navigation